Development of a paediatric physiologically based pharmacokinetic model to assess the impact of drug-drug interactions in tuberculosis co-infected malaria subjects: a case study with artemether-lumefantrine and the CYP3A4-inducer rifampicin

Olusola Olafuyi, Michael Coleman, Raj K.S. Badhan*

*Corresponding author for this work

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Development of a paediatric physiologically based pharmacokinetic model to assess the impact of drug-drug interactions in tuberculosis co-infected malaria subjects: a case study with artemether-lumefantrine and the CYP3A4-inducer rifampicin'. Together they form a unique fingerprint.

Medicine & Life Sciences